RESÚMENES AGOSTO 2009

.

Child & Adolescent Disorders

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana

 

3 - Development of Cortical Asymmetry in Typically Developing Children and Its Disruption in Attention-Deficit/Hyperactivity Disorder

Philip Shaw, Francois Lalonde, Claude Lepage, Cara Rabin, Kristen Eckstrand, Wendy Sharp, Deanna Greenstein, Alan Evans, J. N. Giedd, Judith Rapoport

Arch Gen Psychiatry. 2009;66(8):888-896

 

3! - Efficacy of Reboxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder in Boys With Intolerance to Methylphenidate: An Open-Label, 8-Week, Methylphenidate-Controlled Trial

Cohen-Yavin, Iris; Yoran-Hegesh, Roni; Strous, Rael D; Kotler, Moshe; Weizman, Abraham; Spivak, Baruch

Clinical Neuropharmacology: July/August 2009 - Volume 32 - Issue 4 - pp 179-182

 

3! - Early adversity and 5-HTT/BDNF genes: new evidence of gene–environment interactions on depressive symptoms in a general population

M. Aguilera, B. Arias, M. Wichers, N. Barrantes-Vidal, J. Moya, H. Villa, J. van Os, M. I. Ibáñez, M. A. Ruipérez, G. Ortet and L. Fañanás

Psychological Medicine (2009), 39:1425-1432

 

3! - Mood episodes and mood disorders: patterns of incidence and conversion in the first three decades of life

Katja Beesdo, Michael Höfler, Ellen Leibenluft, Roselind Lieb, Michael Bauer and Andrea Pfennig

Bipolar Disorders. Volume 11 Issue 6, Pages 637 - 649

 

5 - Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder

M Koesters, T Becker, R Kilian, JM Fegert, S Weinmann

Journal of Psychopharmacology, Vol. 23, No. 7, 733-744 (2009)

 

3! - Body Mass Index Changes and Chronic Neuroleptic Drug Treatment for Tourette Syndrome

Roosje S. Degrauw, Jason Z. Li and Donald L. Gilbert

Pediatric Neurology. Volume 41, Issue 3, September 2009, Pages 183-186

 

3 - Use of Atomoxetine in Patients with Attention-Deficit Hyperactivity Disorder and Co-Morbid Conditions

Dell'Agnello, Grazia; Zuddas, Alessandro; Masi, Gabriele; Curatolo, Paolo; Besana, Dante; Rossi, Andrea

CNS Drugs: 1 September 2009 - Volume 23 - Issue 9 - pp 739-753

 

3! - Meta-Analysis: Treatment of Attention-Deficit/Hyperactivity Disorder in Children With Comorbid Tic Disorders

BLOCH, MICHAEL H; PANZA, KAITLYN E; LANDEROS-WEISENBERGER, ANGELI; LECKMAN, JAMES F

Journal of the American Academy of Child & Adolescent Psychiatry: September 2009 - Volume 48 - Issue 9 - pp 884-893

 

3 - Sleep in Children With Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Subjective and Objective Studies

CORTESE, SAMUELE; FARAONE, STEPHEN V; KONOFAL, ERIC; LECENDREUX, MICHEL

Journal of the American Academy of Child & Adolescent Psychiatry: September 2009 - Volume 48 - Issue 9 - pp 894-908

 

3 - Association of Family History of Autoimmune Diseases and Autism Spectrum Disorders

Hjördís Ó. Atladóttir, Marianne G. Pedersen, Cand Scient, Poul Thorsen, Preben Bo Mortensen, Bent Deleuran, William W. Eaton, and Erik T. Parner

PEDIATRICS Vol. 124 No. 2 August 2009, pp. 687-694

 

3! - Dopamine and serotonin transporter genotypes moderate sensitivity to maternal expressed emotion: the case of conduct and emotional problems in attention deficit/hyperactivity disorder

Edmund J.S. Sonuga-Barke, Robert D. Oades, Lamprini Psychogiou, Wai Chen, Barbara Franke, Jan Buitelaar, Tobias Banaschewski, Richard P. Ebstein, Michael Gil, Richard Anney, Ana Miranda, Herbert Roeyers, Aribert Rothenberger, Joseph Sergeant, Hans Christoph Steinhausen, Margaret Thompson, Philip Asherson, and Stephen V. Faraone

Journal of Child Psychology and Psychiatry. Volume 50 Issue 9, Pages 1052 - 1063

 

3 - White matter fractional anisotrophy differences and correlates of diagnostic symptoms in autism

C. Cheung, S.E. Chua, V. Cheung, P.L. Khong , K.S. Tai, T.K.W. Wong, T.P. Ho, and G.M. McAlonan

Journal of Child Psychology and Psychiatry. Volume 50 Issue 9, Pages 1102 - 1112

 

3 - Depression begets depression: Comparing the predictive utility of depression and anxiety symptoms to later depression

Kate Keenan, Xin Feng, Alison Hipwell, and Susan Klostermann

Journal of Child Psychology and Psychiatry. Volume 50 Issue 9, Pages 1167 - 1175

 

5 - Randomized, Placebo-Controlled, Crossover Study of Methylphenidate for Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers with Developmental Disorders

Jaswinder K. Ghuman, Michael G. Aman, Luc Lecavalier, Mark A. Riddle, Alan Gelenberg, Ron Wright, Sydney Rice, Harinder S. Ghuman, Carolyn Fort

Journal of Child and Adolescent Psychopharmacology. August 2009, 19(4): 329-339

 

5 - A Randomized, Double-Blind, Placebo-Controlled Study of Atomoxetine in Japanese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Michihiro Takahashi, Yasushi Takita, Kosuke Yamazaki, Takashi Hayashi, Hironobu Ichikawa, Yasuko Kambayashi, Tatsuya Koeda, Junichi Oki, Kazuhiko Saito, Kenzo Takeshita, Albert J. Allen

Journal of Child and Adolescent Psychopharmacology. August 2009, 19(4): 341-350

 

5 - Efficacy and Safety of Dexmethylphenidate Extended-Release Capsules Administered Once Daily to Children with Attention-Deficit/Hyperactivity Disorder

Ann C. Childress, Thomas Spencer, Frank Lopez, Ortrud Gerstner, Anuradha Thulasiraman, Rafael Muniz, Anke Post

Journal of Child and Adolescent Psychopharmacology. August 2009, 19(4): 351-361

 

3! - Antipsychotic Medication in Children and Adolescents: A Descriptive Review of the Effects on Prolactin Level and Associated Side Effects

Yvette Roke, Peter N. van Harten, Annemieke M. Boot, Jan K. Buitelaar

Journal of Child and Adolescent Psychopharmacology. August 2009, 19(4): 403-414

 

GRATIS 3 - Teenaged Brain: Part 1

John J. Medina

Psychiatric Times. 2009; Vol. 26 No. 8

 

.

Regresar a RESÚMENES AGOSTO 2009

© 1999-2009 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.